3 Cryptos to Buy for 2022
Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."
Just click here to claim your copy today.

AVE Insider Trading (Avecho Biotechnology)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Avecho Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at Avecho Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avecho Biotechnology Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 06/1/2021 01:08 PM ET

This chart shows the closing price history over time for AVE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Buy Live Nation (LYV) Immediately
Wall Street legend who helped create America’s stock-rating system says this stock could soon be rated a “Strong Buy” at every bank in New York City and Boston. “It’s all part of the biggest prediction of my 50-year career on Wall Street,” he says. “A massive and surprising new transition that could determine the next group of millionaires.”
Click here to learn more.

Avecho Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2021Gregory (Greg) CollierInsiderExpiry2,250,000A$0.02A$40,500.00
5/31/2021Matthew McNamaraInsiderIssued3,993,644A$0.02A$75,879.24
See Full Table
Insider Selling at Avecho Biotechnology?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Avecho Biotechnology and related companies.

SEC Filings (Institutional Ownership Changes) for Avecho Biotechnology (ASX:AVE)

Avecho Biotechnology logo
Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, animal health, and nutrition industries in Australia and internationally. The company operates through Production, Human Health, and Other segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 is based in Clayton, Australia.
Read More on Avecho Biotechnology

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Avecho Biotechnology?

Avecho Biotechnology's top insider investors include:
  1. Gregory (Greg) Collier (Insider)
  2. Matthew McNamara (Insider)
3 Cryptos to Buy for 2022
Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."
Just click here to claim your copy today.